In Early-Stage NSCLC, Give Nivolumab Before or After Surgery? In Early-Stage NSCLC, Give Nivolumab Before or After Surgery?
Dr Mark Kris discusses the choice between neoadjuvant and adjuvant nivolumab for patients with early-stage lung cancer.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Lung Cancer | Neoadjuvant Therapy | Non-Small Cell Lung Cancer